Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,976 | 6,163 | 11,431 | 16,685 | 10,822 |
| Operating Income | -3,976 | -6,163 | -11,431 | -16,685 | -10,822 |
| Interest Expense | 571 | 487 | 405 | 300 | 324 |
| Other Income | -419 | -403 | -384 | 13,269 | -910 |
| Pre-tax Income | -4,966 | -7,053 | -12,220 | -3,716 | -12,056 |
| Income Tax | 31 | 48 | 142 | 161 | 187 |
| Net Income Continuous | -4,997 | -7,101 | -12,362 | -3,877 | -12,243 |
| Net Income | $-4,997 | $-7,101 | $-12,362 | $-3,877 | $-12,243 |
| EPS Basic Total Ops | -0.30 | -0.46 | -0.93 | -0.30 | -0.95 |
| EPS Basic Continuous Ops | -0.30 | -0.46 | -0.94 | -0.30 | -0.95 |
| EPS Diluted Total Ops | -0.30 | -0.46 | -0.93 | -0.30 | -0.95 |
| EPS Diluted Continuous Ops | -0.30 | -0.46 | -0.94 | -0.30 | -0.95 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.46 | -0.94 | N/A | N/A |
| EBITDA(a) | $-3,399 | $-5,587 | $-10,405 | $-15,658 | $-9,800 |